Results 41 to 50 of about 13,757,225 (358)

The role of culturally appropriate interpersonal communication strategies to reduce hepatitis B and liver cancer disparities

Frontiers in Public Health
IntroductionAsian and Pacific Islander (API), African, and Caribbean immigrant groups in the U.S. are disproportionately impacted by chronic hepatitis B and hepatocellular carcinoma (primary liver cancer).
Beatrice Zovich, Suzanne J. Block, Fiona Borondy-Jenkins, Kate Moraras, Thomas Chen, Rukayat Adedokun, Dung Hua, Chari Cohen   +7 more
doaj   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li, Binbin Xue, Jia Li, Dewei Xie, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Xu Zhang, Junhui Xia, Jie Lin   +10 more
wiley   +1 more source

The burden of chronic hepatitis B virus infection in Australia, 2011

Australian and New Zealand Journal of Public Health, 2013
Objective: The number of Australians living with chronic hepatitis B (CHB) is thought to be increasing, as are adverse outcomes including cirrhosis and liver cancer, however, robust, up‐to‐date estimates of this burden are limited. Contemporary estimates
Jennifer H. MacLachlan, Nicole Allard, Vanessa Towell, Benjamin C. Cowie   +3 more
doaj   +1 more source

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B

New England Journal of Medicine, 2018
BACKGROUND Pregnant women with an elevated viral load of hepatitis B virus (HBV) have a risk of transmitting infection to their infants, despite the infants' receiving hepatitis B immune globulin.
G. Jourdain, N. Ngo-Giang-Huong, Linda J Harrison, Luc Decker, W. Khamduang, C. Tierney, Nicolas Salvadori, T. Cressey, W. Sirirungsi, J. Achalapong, P. Yuthavisuthi, Prateep Kanjanavikai, O. P. Na Ayudhaya, T. Siriwachirachai, S. Prommas, Prapan Sabsanong, A. Limtrakul, Supang Varadisai, C. Putiyanun, Pornnapa Suriyachai, Prateung Liampongsabuddhi, S. Sangsawang, Wanmanee Matanasarawut, Sudanee Buranabanjasatean, Pichit Puernngooluerm, C. Bowonwatanuwong, T. Puthanakit, V. Klinbuayaem, Satawat Thongsawat, S. Thanprasertsuk, G. Siberry, D. Watts, N. Chakhtoura, T. Murphy, Noele P. Nelson, R. Chung, S. Pol, Nantasak Chotivanich   +37 more
semanticscholar   +1 more source

Management of acute hepatitis B and reactivation of hepatitis B [PDF]

Liver International, 2013
AbstractThe natural course of hepatitis B virus infection and the resulting hepatic injury is determined by the degree of virus replication and the intensity of host immune response. Upon exposure to hepatitis B virus (HBV), individuals with a vigorous and broad immune response develop acute self‐limited infection, which may result in acute hepatitis ...
Manoj Kumar, Shiv Kumar Sarin, Ankur Jindal   +2 more
openaire   +3 more sources

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in LGI1 Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To investigate the value of cytokine, chemokine, and neurofilament light chain (NfL) concentrations in predicting relapse risk, chronic epilepsy, and functional impairment in LGI1 autoimmune encephalitis (AE). Methods Cytokines/chemokines (IL‐1‐beta, IL‐2, IL‐4, IL‐5, IL‐6, IL‐8/CXCL8, IL‐10, IL‐12p70, IL‐13, IL‐17A, GM‐CSF, TNF ...
Albert Aboseif, Georgios Mangioris, Binxia Yang, Vanessa K. Pazdernik, Jeffrey W. Britton, Divyanshu Dubey, Eoin P. Flanagan, Sarosh R. Irani, Gregory S. Day, Charles L. Howe, A. Sebastian López‐Chiriboga, Andrew McKeon, John R. Mills, Yahel Segal, Michel Toledano, Ivana Vodopivec, Sean J. Pittock, Anastasia Zekeridou   +17 more
wiley   +1 more source

Survey of lived experiences and challenges in hepatitis B management and treatment

BMC Public Health
Almost 300 million people are living with chronic hepatitis B infection worldwide and most remain undiagnosed and at risk for liver cancer. In 2015 the World Health Organization (WHO) developed guidelines for the prevention, care, and treatment of ...
Catherine Freeland, Charles Adjei, Jack Wallace, Su Wang, Jessica Hicks, Danjuma Adda, Cary James, Chari Cohen   +7 more
doaj   +1 more source

Photothermal Hydrogel with Mn3O4 Nanoparticles Alleviates Intervertebral Disc Degeneration by Scavenging ROS and Regulating Extracellular Matrix Metabolism

Advanced Functional Materials, EarlyView.
The MPTT‐nanozyme‐hydrogel system (Mn3O4@ChS‐HA) provides a multifunctional therapeutic strategy for intervertebral disc degeneration (IVDD), effectively targeting oxidative stress and enhancing AF repair by restoring extracellular matrix (ECM) and redox homeostasis.
Yangyang Chen, Chan Xue, Feifei Ni, Binwu Hu, Miaoheng Yan, He Zhang, Yuxiang Hu, Xiaoyao Peng, Guangfang Li, Yu Han, Hongjian Liu, Zengwu Shao, Qin Wang, Yulong Wei   +13 more
wiley   +1 more source

Prevention Of Hepatitis B

Journal of Education, Health and Sport, 2017
Kowalska Marta Estera, Kalinowski Paweł, Bojakowska Urszula. Prevention of hepatitis B. Journal of Education, Health and Sport. 2017;7(7):315-321. eISSN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.831803 http://ojs.ukw.edu.pl/index.php/johs/article/view/4628 The journal has had 7 points in Ministry of Science and Higher ...
Urszula Bojakowska, Paweł Kalinowski, Marta Estera Kowalska   +2 more
openaire   +3 more sources

Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy

Advanced Functional Materials, EarlyView.
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang, Huiying Li, Shuodan Huang, Linxuan Zhang, Yan Gao, Ruoran Wang, Xiaoyu Wang, Hélder A. Santos, Zhenyu Yin, Bing Xia   +9 more
wiley   +1 more source